Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

LON/0QQ6 stock hub

LON/0QQ6 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QQ6is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

237.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QQ6

In the news

Latest news · LON/0QQ6

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 12.9P50 16.9P75 23.5

Trailing P/E19.7

P25 15.9P50 22.9P75 35.8

ROE37.3

P25 -54.2P50 2.1P75 13.7

ROIC30.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QQ6 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

CHF

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	103,249
Employees Change	-356%
Employees Change Percent	-0.34
Enterprise value	CHF 258.1B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CH0012032113
Last refreshed	2026-05-10
Market cap	CHF 237.6B
Price	CHF 324
Price currency	CHF
Rev Per Employee	574,969.63x
Sector	Healthcare
Sic	2834
Symbol	lon/0QQ6
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.08%
EV Earnings	21.39x
EV/EBIT	13.07x
EV/EBITDA	11.25x
EV/FCF	18.24x
EV/Sales	4.32x
FCF yield	5.96%
Forward P/E	15.26x
P/B ratio	6.69x
P/E ratio	19.68x
P/S ratio	4x
PE Ratio10 Y	20.24x
PE Ratio3 Y	22.52x
PE Ratio5 Y	20.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.08%
EBITDA Margin	37.95%
FCF margin	23.84%
Gross margin	74.49%
Gross Profit	CHF 44.2B
Gross Profit Growth	-0.6%
Gross Profit Growth Q	-1.22%
Gross Profit Growth3 Y	1.48%
Gross Profit Growth5 Y	0.43%
Net Income	CHF 12.1B
Net Income Growth	55.61%
Net Income Growth Q	170.93%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	6.65%
Net Income Growth5 Y	3.15%
Pretax Margin	26.79%
Profit Margin	20.33%
Profit Per Employee	CHF 116,889
Profitable Years	14
ROA	12.94
Roa5y	13.31
ROCE	28.83
ROE	37.27
Roe5y	38.06
ROIC	30.65
Roic5y	32.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.41%
Cagr1y	17.13%
Cagr3y	5.2%
Cagr5y	3.47%
Div CAGR10	5.99%
Div CAGR3	6.88%
Div CAGR5	7.95%
EPS Growth	55.58
EPS Growth Q	171.3
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	6.61
EPS Growth5 Y	3.23
FCF Growth	-8.82%
FCF Growth Q	-6.66%
FCF Growth3 Y	6.84%
FCF Growth5 Y	3%
OCF Growth	-6.18%
OCF Growth Q	-3.51%
OCF Growth10 Y	0.15%
OCF Growth3 Y	5.38%
OCF Growth5 Y	2.66%
Revenue Growth	1.54x
Revenue Growth Q	-0.42x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	1.5x
Revenue Growth5 Y	0.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.63
Assets	CHF 94.4B
Cash	CHF 14.5B
Current Assets	CHF 36.6B
Current Liabilities	CHF 26.4B
Debt	CHF 31.1B
Debt EBITDA	CHF 1.36
Debt Equity	CHF 0.88
Debt FCF	CHF 2.2
Equity	CHF 35.5B
Interest Coverage	17.66
Liabilities	CHF 58.9B
Long Term Assets	CHF 57.8B
Long Term Liabilities	CHF 32.4B
Net Cash	CHF -16.6B
Net Cash By Market Cap	CHF -6.99
Net Debt EBITDA	CHF 0.74
Net Debt Equity	CHF 0.47
Net Debt FCF	CHF 1.17
Tangible Book Value	CHF 6.5B
Tangible Book Value Per Share	CHF 8.23
WACC	5.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Inventory Turnover	2.14
Net Working Capital	CHF -220.2M
Quick ratio	1.05
Working Capital	CHF 10.1B
Working Capital Turnover	CHF 5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.13%
Dividend Growth	21.48%
Dividend Growth Years	0%
Dividend per share	CHF 10.31
Dividend Years	13
Dividend Yield	3.18%
Ex Div Date	2026-03-12
Last Dividend	CHF 10.31
Payout Frequency	Annual
Payout Ratio	60.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	86.16%
1Y total return	17.11%
200-day SMA	314.7
3Y total return	16.44%
50-day SMA	333.8
50-day SMA vs 200-day SMA	50over200
5Y total return	18.58%
All Time High	438.8
All Time High Change	-26.18%
All Time High Date	2022-04-11
All Time Low	211.6
All Time Low Change	53.07%
All Time Low Date	2018-06-11
ATR	5.95
Beta	0.33
Ch YTD	-3.93
High	325
High52	382.7
High52 Date	2026-02-24
High52ch	-15.36%
Low	322
Low52	257
Low52 Date	2025-08-12
Low52ch	26.03%
Ma50ch	-2.96%
Price vs 200-day SMA	2.93%
RSI	43.18
RSI Monthly	53.8
RSI Weekly	48.16
Sharpe ratio	0.52x
Sortino ratio	1.04
Total Return	3.06%
Tr YTD	-0.79
Tr1m	0.93%
Tr1w	-0.79%
Tr3m	-7.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 19.6B
Operating Income Growth	3.35
Operating Income Growth Q	7.74
Operating Income Growth3 Y	5.2
Operating Income Growth5 Y	1.99
Operating margin	33.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	652,938,195%
Net Borrowing	-489,981,744.1
Shares Insiders	17.93%
Shares Institutions	15.4%
Shares Qo Q	0%
Shares Yo Y	0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 13.3B
Average Volume	3,851.25x
Bv Per Share	39.81
CAPEX	CHF -3.5B
Ch10y	35.1
Ch1m	0.93
Ch1w	-0.79
Ch1y	13.4
Ch3m	-10.79
Ch3y	5.22
Ch5y	1.09
Ch6m	16.01
Change	-0.7%
Change From Open	-0.21
Close	326.2
Days Gap	-0.49
Depreciation Amortization	2,913,455,996.8
Dollar Volume	498,490.3
Earnings Date	2026-07-23
EBIT	CHF 19.6B
EBITDA	CHF 22.5B
EPS	CHF 15.03
F Score	5
FCF	CHF 14.2B
FCF EV Yield	5.48x
Financing CF	-10,651,899,873
Fiscal Year End	December
Founded	1,896
Goodwill	7,073,108,337
Graham Number	133.86254
Graham Upside	-58.67
Income Tax	CHF 3B
Investing CF	-8,004,854,030
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Lynch Fair Value	CHF 82.28
Lynch Upside	-74.6
Ma150	328.3
Ma150ch	-1.35%
Ma20	328.1
Ma20ch	-1.28%
Net CF	-1,305,251,278
Next Earnings Date	2026-07-23
Open	324.6
P FCF Ratio	16.78
P OCF Ratio	13.45
Payment Date	2026-03-16
Position In Range	63.51
Ppne	21,651,717,378.7
Price Date	2026-05-08
Price EBITDA	CHF 10.54
Ptbv Ratio	36.27
Relative Volume	0.4x
Revenue	59,365,039,441x
SBC By Revenue	1.35x
Share Based Comp	803,015,323
Tax By Revenue	5.01x
Tax Rate	18.7%
Tr6m	19.81%
Volume	1,539
Z Score	4.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QQ6 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.2%

$10.3 annual per share

Payout ratio

+60.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.9%

0 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-03-12

Performance

LON/0QQ6 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QQ6?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.4%

Share of float held by funds and institutions

Insider ownership

+17.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0QQ6 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.2

Neutral momentum band

Price vs 200-day MA

+2.9%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QQ6

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QQ6 stock rating?

lon/0QQ6 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QQ6 analysis?

The full report lives at /stocks/lon/0QQ6/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QQ6?

The latest report frames lon/0QQ6 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QQ6 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.